Cc1cc(C)c(-c2cc([C@H](C)O/N=C\[C@@H](C)[C@H](OCc3ccccc3)C(C)C)on2)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?